We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Top Buys

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$55.3M
2
AAPL icon
Apple
AAPL
+$33.2M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
MSFT icon
Microsoft
MSFT
+$26.4M
5
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$22.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$93.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$51.5M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XCUR icon
4176
Exicure
XCUR
$8.35M
$7K ﹤0.01%
20
-28
-58% -$10.1K
SER icon
4177
Serina Therapeutics
SER
$38.1M
$7K ﹤0.01%
217
+174
+405% +$5.12K
SCX
4178
DELISTED
The L.S. Starrett Company
SCX
$7K ﹤0.01%
1,920
+1,896
+7,900% +$6.45K
ICD
4179
DELISTED
Independence Contract Drilling, Inc.
ICD
$7K ﹤0.01%
1,928
+600
+45% +$3.53K
CBD
4180
DELISTED
Companhia Brasileira de Distribuicao
CBD
$7K ﹤0.01%
598
-9,323
-94% -$113K
LMNL
4181
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$7K ﹤0.01%
70
-30
-30% -$2.65K
AVCT
4182
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$7K ﹤0.01%
+138
New +$4.87K
MN
4183
DELISTED
MANNING & NAPIER, INC.
MN
$7K ﹤0.01%
+2,400
New +$6.8K
CTEK
4184
DELISTED
CynergisTek, Inc.
CTEK
$7K ﹤0.01%
+4,776
New +$8.04K
IEC
4185
DELISTED
IEC Electronics Corp.
IEC
$7K ﹤0.01%
775
-341
-31% -$2.69K
OCSI
4186
DELISTED
Oaktree Strategic Income Corporation
OCSI
$7K ﹤0.01%
1,028
-2,561
-71% -$15.5K
SNDE
4187
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$7K ﹤0.01%
+2,529
New +$7.26K
IPOB.U
4188
DELISTED
Social Capital Hedosophia Holdings Corp. II Units, each consisting of one Class A ordinary share and
IPOB.U
$7K ﹤0.01%
+521
New +$5.72K
NBRV
4189
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$7K ﹤0.01%
42
– –
IDXG
4190
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$7K ﹤0.01%
+1,404
New +$7.28K
CEMI
4191
DELISTED
Chembio diagnostics, Inc.
CEMI
$7K ﹤0.01%
2,116
+2,016
+2,016% +$19.1K
ACB
4192
Aurora Cannabis
ACB
$177M
$6K ﹤0.01%
50
-157
-76% -$17.9K
AHCO icon
4193
AdaptHealth
AHCO
$711M
$6K ﹤0.01%
+395
New +$6.6K
AMTX icon
4194
Aemetis
AMTX
$121M
$6K ﹤0.01%
+6,909
New +$5.02K
ARKR icon
4195
Ark Restaurants
ARKR
$20.2M
$6K ﹤0.01%
415
+367
+765% +$4.31K
ATER icon
4196
Aterian
ATER
$5.25M
$6K ﹤0.01%
91
-81
-47% -$3.92K
ATOS icon
4197
Atossa Therapeutics
ATOS
$24.3M
$6K ﹤0.01%
+112
New +$3.97K
BCDA icon
4198
BioCardia
BCDA
$14.3M
$6K ﹤0.01%
+173
New +$9.37K
BF.A icon
4199
Brown-Forman Class A
BF.A
$13.1B
$6K ﹤0.01%
+102
New +$5.95K
BNO icon
4200
United States Brent Oil Fund
BNO
$775M
$6K ﹤0.01%
600
-600
-50% -$5.49K
166 167
168
169 170

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.